Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Chandler

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Psychosomatics|January 1, 1988
The role of the medical evaluation in psychiatric inpatientsJ D Chandler, J E Gerndt
British Journal of Pharmacology|April 17, 2013
Nebulized thiocyanate improves lung infection outcomes in miceJ D Chandler, E Min, J Huang, et al.
Veterinary Microbiology|September 29, 1999
Serological evidence for swine hepatitis E virus infection in Australian pig herdsJ D Chandler, M A Riddell, F Li, et al.
Journal of Virology|November 13, 1998
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virusS J Kent, A Zhao, S J Best, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Psychosomatics|January 1, 1988
The role of the medical evaluation in psychiatric inpatientsJ D Chandler, J E Gerndt
British Journal of Pharmacology|April 17, 2013
Nebulized thiocyanate improves lung infection outcomes in miceJ D Chandler, E Min, J Huang, et al.
Veterinary Microbiology|September 29, 1999
Serological evidence for swine hepatitis E virus infection in Australian pig herdsJ D Chandler, M A Riddell, F Li, et al.
Journal of Virology|November 13, 1998
Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virusS J Kent, A Zhao, S J Best, et al.
Pageof 2